TNFRSF10B and cancer: Interestingly, TRAIL-R1 and TRAIL-R2 are commonly overexpressed in cancer cells, but are frequently detected intracellularly and high intracellular abundance, especially of TRAIL-R2, was correlated with poor patient prognosis [13].